Daejeon, South Korea

Jae-Young Yang

This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae-Young Yang. Retrieved from https://idiyas.com/inventor/jae-young-yang-5ojq7t3t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jae-Young Yang: Innovator in Anticancer Research

Introduction

Jae-Young Yang is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of bioscience and biotechnology, particularly in the development of anticancer compositions. His innovative work aims to provide new therapeutic options for cancer treatment.

Latest Patents

Jae-Young Yang holds a patent for an anticancer composition comprising obovatol or obovatal. This composition is designed to inhibit the growth of cancer cells and suppress the expression and activity of matrix metalloproteinases (MMPs). The patent highlights the potential of this composition for the prophylaxis and treatment of cancer, as well as for the inhibition of cancer metastasis. He has 1 patent to his name.

Career Highlights

Yang is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he conducts his research. His work is characterized by a commitment to advancing cancer treatment through innovative scientific approaches.

Collaborations

Some of his notable coworkers include Byoung-Mog Kwon and Kwang-Hee Son, who contribute to the collaborative efforts in their research projects.

Conclusion

Jae-Young Yang's contributions to anticancer research exemplify the importance of innovation in the fight against cancer. His work not only enhances our understanding of cancer treatment but also opens new avenues for therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…